HistoSonics
About HistoSonics
HistoSonics is a medical technology company developing a non-invasive, robotically assisted platform that employs histotripsy to destroy targeted liver tumors at a sub-cellular level. The company focuses on advancing histotripsy as a novel focused ultrasound therapy, bringing this technology to physicians and patients worldwide. Their communications emphasize clinical evidence, education, and evidence-based trials related to histotripsy. Headquartered in the United States, they position themselves as a leader in non-invasive liver tumor treatment using ultrasonic energy.
Recent News
HistoSonics Moves to Advance Additional Histotripsy Applications Announcing FDA Submission for Kidney Tumors
US Department of Health and Human Services Launches $4million National Competition for Innovations in Living Kidney Donation
FEATURE: From Lab Idea to $2.25 Billion: Ultrasound Destroys Cancer without Scalpels